Advanced search
Publication Cover
Cancer Investigation Volume 25, 2007 - Issue 7
Submit an article Journal homepage
19
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

Dose-Intense PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) in Advanced Pancreatic Adenocarcinoma: A Dose-Finding Study

M. Reni Department of Oncology, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D.,
S. Cereda Department of Oncology, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D.,
E. Bonetto Department of Oncology, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D.,
M. G. Viganò Department of Oncology, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D.,
P. Passoni Department of Oncology, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D.,
A. Zerbi Department of Surgery, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D.,
G. Balzano Department of Surgery, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D.,
R. Nicoletti Department of Radiology, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D.,
C. Staudacher Department of Surgery, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D. &
V. Di Carlo Department of Surgery, S. Raffaele H. Scientific Institute, Milan, Italy
, M.D. show all
Pages 594-598 | Published online: 11 Jun 2009

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lucia Lombardi, Michele Troiano, Nicola Silvestris, Luciano Nanni, Tiziana Pia Latiano, Gabriele Di Maggio, Saverio Cinieri, Pierluigi Di Sebastiano, Giuseppe Colucci & Evaristo Maiello. (2012) Combined modality treatments in pancreatic cancer. Expert Opinion on Therapeutic Targets 16:sup2, pages S71-S81.
Read now

Articles from other publishers (10)

Michele Reni, Umberto Peretti, Silvia Zanon, Marina Macchini, Gianpaolo Balzano, Elena Mazza, Domenico Tamburrino, Giulia Orsi, Paolo Giorgio Arcidiacono, Massimo Falconi & Luca Gianni. (2020) Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology 85:4, pages 641-650.
Crossref
Vanja Vaccaro. (2015) Metastatic pancreatic cancer: Is there a light at the end of the tunnel?. World Journal of Gastroenterology 21:16, pages 4788.
Crossref
Amir Avan, Paola Pacetti, Michele Reni, Michele Milella, Enrico Vasile, Andrea Mambrini, Vanja Vaccaro, Sara Caponi, Stefano Cereda, Godefridus J. Peters, Maurizio Cantore & Elisa Giovannetti. (2013) Prognostic factors in gemcitabine–cisplatin polychemotherapy regimens in pancreatic cancer: XPD‐Lys751Gln polymorphism strikes back . International Journal of Cancer 133:4, pages 1016-1022.
Crossref
Carmen Belli, Stefano Cereda, Santosh Anand & Michele Reni. (2013) Neoadjuvant therapy in resectable pancreatic cancer: A critical review. Cancer Treatment Reviews 39:5, pages 518-524.
Crossref
Michele Reni, Gianpaolo Balzano, Giuseppe Aprile, Stefano Cereda, Paolo Passoni, Alessandro Zerbi, Maria Chiara Tronconi, Carlo Milandri, Piercarlo Saletti, Alessia Rognone, Clara Fugazza, Alessandro Magli, Nadia Di Muzio, Valerio Di Carlo & Eugenio Villa. (2012) Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial. Annals of Surgical Oncology 19:7, pages 2256-2263.
Crossref
Michele Reni, Stefano Cereda, Alessia Rognone, Carmen Belli, Michele Ghidini, Simonetta Longoni, Clara Fugazza, Sara Rezzonico, Paolo Passoni, Najla Slim, Giampaolo Balzano, Roberto Nicoletti, Stefano Cappio, Claudio Doglioni & Eugenio Villa. (2011) A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). Cancer Chemotherapy and Pharmacology 69:1, pages 115-123.
Crossref
M. Reni, S. Cereda, C. Belli & E. Villa. (2011) Unity is strength: one, two, or more drugs against advanced pancreatic cancer?. Annals of Oncology 22:4, pages 987.
Crossref
Michele Reni, Nora Sartori, Andrea Mambrini, Rossana Berardi, Alessandro Passardi, Michele Milella, Stefano Cereda, Maria Chiara Tronconi, Giuseppe Aprile, Stefano Cordio, Lara Maria Pasetto, Alessia Rognone, Paolo Pederzoli & Massimo Falconi. (2010) An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change?. Anti-Cancer Drugs 21:4, pages 459-464.
Crossref
Michele Reni, S. Cereda, G. Balzano, P. Passoni, A. Rognone, A. Zerbi, R. Nicoletti, E. Mazza, P. G. Arcidiacono, V. Di Carlo & E. Villa. (2009) Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma. Cancer Chemotherapy and Pharmacology 64:6, pages 1253-1259.
Crossref
Michele Reni, Stefano Cereda, Gianpaolo Balzano, Paolo Passoni, Alessia Rognone, Clara Fugazza, Elena Mazza, Alessandro Zerbi, Valerio Di Carlo & Eugenio Villa. (2009) Carbohydrate antigen 19‐9 change during chemotherapy for advanced pancreatic adenocarcinoma. Cancer 115:12, pages 2630-2639.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.